Karolinska Institutet

Company

Related News

Immunotherapy Expands to Earlier Cancer Stages Across Multiple Tumor Types

Immunotherapy is increasingly used in earlier cancer stages before or after surgery across seven tumor areas. Research shows neoadjuvant and adjuvant immunotherapy can reduce recurrence risk and improve immune recognition of tumor cells. However, challenges remain including side effects, costs, and determining which patients benefit most from earlier treatment.

AI and New Drug Targets Advance Alzheimer's Research Pipeline

Artificial intelligence is increasingly used to analyze Alzheimer's datasets and inform drug discovery, while researchers identify promising new drug targets including the IDOL enzyme and somatostatin receptors that could lead to more affordable treatments.

Related Clinical Trials

NCT ID Title Status Phase
NCT07773948

ASAPP Study - Topical 5-ASA as Prophylaxis for Pouchitis in Ulcerative Colitis Patients After Pelvic Pouch Surgery

NOT_YET_RECRUITING PHASE4
NCT07772128

Evaluating the Feasibility and Effects of PULS

NOT_YET_RECRUITING NA
NCT07766863

AI-support in Emergency Medicine

RECRUITING
NCT07761923

Preserving Muscle Mass During Incretin-Induced Weight Loss

NOT_YET_RECRUITING NA
NCT07758946

Endoexpedition - Use of a Serious Game to Deliver Patient Information and Decision Aid for Individuals With Endometriosis.

NOT_YET_RECRUITING NA
NCT07757854

Exposure Therapy for Reactivity to Symptoms

NOT_YET_RECRUITING NA
NCT07755774

Psychological Treatment for Adolescents With Self-injury Within Intensive Mental Health Outpatient Services: Randomized Controlled Pilot Trial

NOT_YET_RECRUITING NA
NCT07746310

Dietary Nitrate and Nitrite Intake and Phosphate Biomarkers and Risk of Chronic Diseases

COMPLETED
NCT07720063

Group Treatment for Self-harming Adolescents and Their Parents: a Randomized Controlled Trial

NOT_YET_RECRUITING NA
NCT07715214

Prenatal Blood Typing With Next Generation Sequencing (NGS) - an Implementation Study in HDFN (PREFAB)

NOT_YET_RECRUITING NA